by TractManager | Aug 15, 2023 | Emerging Technology Report
Nirsevimab-alip (Beyfortus; AstraZeneca) is a respiratory syncytial virus (RSV) F protein-directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease in neonates and infants born during or entering their first RSV season, and for...
by TractManager | Aug 15, 2023 | Emerging Technology Report
Avasopasem manganese (Galera Therapeutics Inc.) is an investigational intravenous superoxide dismutase mimetic intended to reduce the incidence and severity of radiation-induced oral mucositis in patients undergoing radiotherapy for head and neck cancer.
by TractManager | Aug 14, 2023 | Emerging Technology Report
The AccuCinch Ventricular Restoration System (Ancora Heart Inc.) is a transcatheter left ventricular cinching device proposed for treatment of symptomatic heart failure with reduced ejection fraction (HFrEF).
by TractManager | Aug 8, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the Vectra test (Laboratory Corporation of America Holdings).
by TractManager | Aug 7, 2023 | Molecular Test Assessment
This report evaluates the clinical validity and clinical utility of the Cxbladder Monitor test.
Recent Comments